Faye Robertson is a Consultant Clinical Oncologist (NHS Lothian) and an Honorary Senior Clinical Lecturer (University of Edinburgh).

She has a PhD in glioblastoma stem cell biology and is the Chief Investigator of the forthcoming ADePT study of a novel genetic immunotherapy for glioblastoma, sponsored by Trogenix.